TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs4538475
log Bayes Factor = <0.0001
Chromosome 4   position 15,737,937  (GRCh37) Explore rs4538475 on Ensembl!
Variant rs4538475 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.967 0.033
T40.2 Other opioids
0.000 0.968 0.032
T43.2 Other and unspecified antidepressants
0.000 0.969 0.031
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.969 0.031
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.971 0.029
T40.4 Other synthetic narcotics
0.000 0.971 0.029
N41.1 Chronic prostatitis
0.000 0.971 0.029
T39.1 4-Aminophenol derivatives
0.000 0.971 0.029
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.972 0.028
N41.9 Inflammatory disease of prostate, unspecified
0.000 0.972 0.028
N41 Inflammatory diseases of prostate
0.000 0.974 0.026
T40.6 Other and unspecified narcotics
0.000 0.974 0.026
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.974 0.026
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.974 0.026
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.974 0.026
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.976 0.024
T40.8 Lysergide [LSD]
0.000 0.976 0.024
T40.7 Cannabis (derivatives)
0.000 0.976 0.024
T40.5 Cocaine
0.000 0.976 0.024
T40.3 Methadone
0.000 0.976 0.024
T40.1 Heroin
0.000 0.976 0.024
T40.0 Opium
0.000 0.976 0.024
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.977 0.023
T36 Poisoning by systemic antibiotics
0.000 0.977 0.023
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.977 0.023
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.977 0.022
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.978 0.022
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.978 0.022
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.978 0.022
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.978 0.022
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.978 0.022
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.978 0.022
T43.6 Psychostimulants with abuse potential
0.000 0.978 0.022
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.978 0.022
T43.9 Psychotropic drug, unspecified
0.000 0.979 0.021
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.979 0.021
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.979 0.021
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.979 0.021
T46.1 Calcium-channel blockers
0.000 0.979 0.021
T42.4 Benzodiazepines
0.000 0.979 0.021
T39.4 Antirheumatics, not elsewhere classified
0.000 0.979 0.021
T39.2 Pyrazolone derivatives
0.000 0.979 0.021
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.979 0.021
N41.0 Acute prostatitis
0.000 0.980 0.020
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.980 0.020
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.980 0.020
N41.8 Other inflammatory diseases of prostate
0.000 0.981 0.019
N41.3 Prostatocystitis
0.000 0.981 0.019
N41.2 Abscess of prostate
0.000 0.981 0.019
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.981 0.019
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.981 0.019
T42.3 Barbiturates
0.000 0.981 0.019
T42.2 Succinimides and oxazolidinediones
0.000 0.981 0.019
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.981 0.019
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.981 0.019
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.981 0.019
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.981 0.019
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.981 0.019
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.981 0.019
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.981 0.019
T44.0 Anticholinesterase agents
0.000 0.981 0.019
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.981 0.019
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.981 0.019
T46.7 Peripheral vasodilators
0.000 0.981 0.019
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.981 0.019
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.981 0.019
T42.0 Hydantoin derivatives
0.000 0.981 0.018
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.982 0.018
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.982 0.018
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.982 0.018
T42.1 Iminostilbenes
0.000 0.982 0.017
T36.0 Penicillins
0.000 0.983 0.017
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.983 0.017
T36.9 Systemic antibiotic, unspecified
0.000 0.983 0.017
T36.8 Other systemic antibiotics
0.000 0.983 0.017
T36.7 Antifungal antibiotics, systemically used
0.000 0.983 0.017
T36.6 Rifamycins
0.000 0.983 0.017
T36.5 Aminoglycosides
0.000 0.983 0.017
T36.4 Tetracyclines
0.000 0.983 0.017
T36.3 Macrolides
0.000 0.983 0.017
T36.2 Chloramphenicol group
0.000 0.983 0.017
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.983 0.017
T39.0 Salicylates
0.000 0.983 0.017
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.983 0.016
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.984 0.016
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.984 0.016
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.984 0.016
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.984 0.016
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.984 0.016
T37.5 Antiviral drugs
0.000 0.984 0.016
T37.4 Anthelminthics
0.000 0.984 0.016
T37.3 Other antiprotozoal drugs
0.000 0.984 0.016
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.984 0.016
T37.1 Antimycobacterial drugs
0.000 0.984 0.016
T37.0 Sulphonamides
0.000 0.984 0.016
T41.5 Therapeutic gases
0.000 0.984 0.016
T41.4 Anaesthetic, unspecified
0.000 0.984 0.016
T41.3 Local anaesthetics
0.000 0.984 0.016
T41.2 Other and unspecified general anaesthetics
0.000 0.984 0.016
T41.1 Intravenous anaesthetics
0.000 0.984 0.016
T41.0 Inhaled anaesthetics
0.000 0.984 0.016
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.984 0.016
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.984 0.016
T48.5 Anti-common-cold drugs
0.000 0.984 0.016
T48.4 Expectorants
0.000 0.984 0.016
T48.3 Antitussives
0.000 0.984 0.016
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.984 0.016
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.984 0.016
T48.0 Oxytocic drugs
0.000 0.984 0.016
T49.9 Topical agent, unspecified
0.000 0.984 0.016
T49.8 Other topical agents
0.000 0.984 0.016
T49.7 Dental drugs, topically applied
0.000 0.984 0.016
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.984 0.016
T49.5 Ophthalmological drugs and preparations
0.000 0.984 0.016
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.984 0.016
T49.3 Emollients, demulcents and protectants
0.000 0.984 0.016
T49.2 Local astringents and local detergents
0.000 0.984 0.016
T49.1 Antipruritics
0.000 0.984 0.016
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.984 0.016
Z73.8 Other problems related to life-management difficulty
0.016 0.984 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.984 0.016
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.985 0.015
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.985 0.015
T47.7 Emetics
0.000 0.985 0.015
T47.6 Antidiarrhoeal drugs
0.000 0.985 0.015
T47.5 Digestants
0.000 0.985 0.015
T47.4 Other laxatives
0.000 0.985 0.015
T47.3 Saline and osmotic laxatives
0.000 0.985 0.015
T47.0 Histamine H(2)-receptor antagonists
0.000 0.985 0.015
Z73 Problems related to life-management difficulty
0.013 0.987 0.000
T50.8 Diagnostic agents
0.000 0.987 0.013
T50.7 Analeptics and opioid receptor antagonists
0.000 0.987 0.013
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.987 0.013
T50.5 Appetite depressants
0.000 0.987 0.013
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.987 0.013
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.987 0.013
T50.1 Loop [high-ceiling] diuretics
0.000 0.987 0.013
T50.0 Mineralocorticoids and their antagonists
0.000 0.987 0.013
T47.2 Stimulant laxatives
0.000 0.987 0.013
H40.1 Primary open-angle glaucoma
0.013 0.987 0.000
T45.0 Antiallergic and antiemetic drugs
0.000 0.987 0.012
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.988 0.012
T45.8 Other primarily systemic and haematological agents
0.000 0.988 0.012
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.988 0.012
T45.6 Fibrinolysis-affecting drugs
0.000 0.988 0.012
T45.4 Iron and its compounds
0.000 0.988 0.012
T45.3 Enzymes, not elsewhere classified
0.000 0.988 0.012
T45.2 Vitamins, not elsewhere classified
0.000 0.988 0.012
T38.9 Other and unspecified hormone antagonists
0.000 0.988 0.012
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.988 0.012
T38.7 Androgens and anabolic congeners
0.000 0.988 0.012
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.988 0.012
T38.5 Other oestrogens and progestogens
0.000 0.988 0.012
T38.4 Oral contraceptives
0.000 0.988 0.012
T38.2 Antithyroid drugs
0.000 0.988 0.012
T38.0 Glucocorticoids and synthetic analogues
0.000 0.988 0.012
Z73.9 Problem related to life-management difficulty, unspecified
0.012 0.988 0.000
Z73.3 Stress, not elsewhere classified
0.012 0.988 0.000
T50.4 Drugs affecting uric acid metabolism
0.000 0.988 0.011
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.989 0.011
C16.0 Cardia
0.011 0.989 0.000
T38.1 Thyroid hormones and substitutes
0.000 0.989 0.011
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.989 0.011
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.990 0.010
T78.2 Anaphylactic shock, unspecified
0.010 0.990 0.000
Z73.5 Social role conflict, not elsewhere classified
0.010 0.990 0.000
Z73.4 Inadequate social skills, not elsewhere classified
0.010 0.990 0.000
Z73.2 Lack of relaxation and leisure
0.010 0.990 0.000
Z73.1 Accentuation of personality traits
0.010 0.990 0.000
Z73.0 Burn-out
0.010 0.990 0.000
T78 Adverse effects, not elsewhere classified
0.010 0.990 0.000
Z73.6 Limitation of activities due to disability
0.009 0.991 0.000
T45.5 Anticoagulants
0.000 0.991 0.008
T78.4 Allergy, unspecified
0.008 0.992 0.000
C16 Malignant neoplasm of stomach
0.008 0.992 0.000
T68 Hypothermia
0.008 0.992 0.000
T78.0 Anaphylactic shock due to adverse food reaction
0.008 0.992 0.000
R03.1 Nonspecific low blood-pressure reading
0.008 0.992 0.000
Z45.0 Adjustment and management of cardiac pacemaker
0.000 0.992 0.008
T78.8 Other adverse effects, not elsewhere classified
0.008 0.992 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.992 0.008
T66-T78 Other and unspecified effects of external causes
0.008 0.992 0.000
T78.1 Other adverse food reactions, not elsewhere classified
0.008 0.992 0.000
C16.5 Lesser curvature of stomach, unspecified
0.007 0.993 0.000
T78.9 Adverse effect, unspecified
0.007 0.993 0.000
C16.9 Stomach, unspecified
0.007 0.993 0.000
Y84.8 Other medical procedures
0.007 0.993 0.000
C16.1 Fundus of stomach
0.007 0.993 0.000
C16.4 Pylorus
0.007 0.993 0.000
R59.1 Generalised enlarged lymph nodes
0.000 0.993 0.007
C16.3 Pyloric antrum
0.006 0.993 0.000
C16.6 Greater curvature of stomach, unspecified
0.006 0.994 0.000
Z75 Problems related to medical facilities and other health care
0.006 0.994 0.000
C16.8 Overlapping lesion of stomach
0.006 0.994 0.000
Z99.8 Dependence on other enabling machines and devices
0.006 0.994 0.000
T71 Asphyxiation
0.006 0.994 0.000
Z75.1 Person awaiting admission to adequate facility elsewhere
0.006 0.994 0.000
Z75.3 Unavailability and inaccessibility of health-care facilities
0.006 0.994 0.000
Z30.1 Insertion of (intra-uterine) contraceptive device
0.006 0.994 0.000
Z75.8 Other problems related to medical facilities and other health care
0.006 0.994 0.000
T66 Unspecified effects of radiation
0.006 0.994 0.000
C16.2 Body of stomach
0.006 0.994 0.000
T74 Maltreatment syndromes
0.006 0.994 0.000
T73 Effects of other deprivation
0.006 0.994 0.000
T69 Other effects of reduced temperature
0.006 0.994 0.000
T67 Effects of heat and light
0.006 0.994 0.000
T78.3 Angioneurotic oedema
0.006 0.994 0.000
U88 Agent resistant to multiple antibiotics
0.006 0.994 0.000
Y84.1 Kidney dialysis
0.006 0.994 0.000
T75 Effects of other external causes
0.005 0.995 0.000
Z75.5 Holiday relief care
0.005 0.995 0.000
T70 Effects of air pressure and water pressure
0.005 0.995 0.000
Z70-Z76 Persons encountering health services in other circumstances
0.005 0.995 0.000
Z75.9 Unspecified problem related to medical facilities and other health care
0.005 0.995 0.000
Z75.0 Medical services not available in home
0.005 0.995 0.000
L71.9 Rosacea, unspecified
0.005 0.995 0.000
Z75.4 Unavailability and inaccessibility of other helping agencies
0.004 0.995 0.000
M79.84 Other specified soft tissue disorders (Hand)
0.005 0.995 0.000
T67.9 Effects of heat and light, unspecified
0.004 0.996 0.000
T67.8 Other effects of heat and light
0.004 0.996 0.000
T67.7 Heat oedema
0.004 0.996 0.000
T67.6 Heat fatigue, transient
0.004 0.996 0.000
T67.5 Heat exhaustion, unspecified
0.004 0.996 0.000
T67.4 Heat exhaustion due to salt depletion
0.004 0.996 0.000
T67.3 Heat exhaustion, anhydrotic
0.004 0.996 0.000
T67.2 Heat cramp
0.004 0.996 0.000
T67.1 Heat syncope
0.004 0.996 0.000
T67.0 Heatstroke and sunstroke
0.004 0.996 0.000
T69.9 Effect of reduced temperature, unspecified
0.004 0.996 0.000
T69.8 Other specified effects of reduced temperature
0.004 0.996 0.000
T69.1 Chilblains
0.004 0.996 0.000
T69.0 Immersion hand and foot
0.004 0.996 0.000
T73.9 Effect of deprivation, unspecified
0.004 0.996 0.000
T73.8 Other effects of deprivation
0.004 0.996 0.000
T73.3 Exhaustion due to excessive exertion
0.004 0.996 0.000
T73.2 Exhaustion due to exposure
0.004 0.996 0.000
T73.1 Effects of thirst
0.004 0.996 0.000
T73.0 Effects of hunger
0.004 0.996 0.000
T74.9 Maltreatment syndrome, unspecified
0.004 0.996 0.000
T74.8 Other maltreatment syndromes
0.004 0.996 0.000
T74.3 Psychological abuse
0.004 0.996 0.000
T74.2 Sexual abuse
0.004 0.996 0.000
T74.1 Physical abuse
0.004 0.996 0.000
T74.0 Neglect or abandonment
0.004 0.996 0.000
Z74.2 Need for assistance at home and no other household member able to render care
0.004 0.996 0.000
Z74 Problems related to care-provider dependency
0.004 0.996 0.000
T75.8 Other specified effects of external causes
0.004 0.996 0.000
T75.3 Motion sickness
0.004 0.996 0.000
T75.2 Effects of vibration
0.004 0.996 0.000
T75.1 Drowning and nonfatal submersion
0.004 0.996 0.000
T75.0 Effects of lightning
0.004 0.996 0.000
T70.9 Effect of air pressure and water pressure, unspecified
0.004 0.996 0.000
T70.8 Other effects of air pressure and water pressure
0.004 0.996 0.000
T70.4 Effects of high-pressure fluids
0.004 0.996 0.000
T70.2 Other and unspecified effects of high altitude
0.004 0.996 0.000
T70.1 Sinus barotrauma
0.004 0.996 0.000
T70.0 Otitic barotrauma
0.004 0.996 0.000
M79.8 Other specified soft tissue disorders
0.004 0.996 0.000
Z70 Counselling related to sexual attitude, behaviour and orientation
0.004 0.996 0.000
M75.5 Bursitis of shoulder
0.000 0.996 0.004
K12.1 Other forms of stomatitis
0.004 0.996 0.000
T75.4 Effects of electric current
0.004 0.996 0.000
Z75.2 Other waiting period for investigation and treatment
0.003 0.996 0.000
Z74.1 Need for assistance with personal care
0.003 0.996 0.000
M79.80 Other specified soft tissue disorders (Multiple sites)
0.003 0.996 0.000
M79.89 Other specified soft tissue disorders (Site unspecified)
0.003 0.997 0.000
T70.3 Caisson disease [decompression sickness]
0.003 0.997 0.000
Y84 Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
0.003 0.997 0.000
M79.86 Other specified soft tissue disorders (Lower leg)
0.003 0.997 0.000
S82.80 Fractures of other parts of lower leg (closed)
0.000 0.997 0.003
D69.3 Idiopathic thrombocytopenic purpura
0.003 0.997 0.000
M79.85 Other specified soft tissue disorders (Pelvic region and thigh)
0.003 0.997 0.000
I49.8 Other specified cardiac arrhythmias
0.000 0.997 0.003
L43.9 Lichen planus, unspecified
0.000 0.997 0.003
Z74.3 Need for continuous supervision
0.003 0.997 0.000
M25.54 Pain in joint (Hand)
0.003 0.997 0.000
M79 Other soft tissue disorders, not elsewhere classified
0.003 0.997 0.000
M79.99 Soft tissue disorder, unspecified (Site unspecified)
0.003 0.997 0.000
M79.9 Soft tissue disorder, unspecified
0.003 0.997 0.000
M79.7 Fibromyalgia
0.003 0.997 0.000
M79.81 Other specified soft tissue disorders (Shoulder region)
0.003 0.997 0.000
Z76 Persons encountering health services in other circumstances
0.003 0.997 0.000
Z70.9 Sex counselling, unspecified
0.003 0.997 0.000
Z70.8 Other sex counselling
0.003 0.997 0.000
Z70.3 Counselling related to combined concerns regarding sexual attitude, behaviour and orientation
0.003 0.997 0.000
Z70.2 Counselling related to sexual behaviour and orientation of third party
0.003 0.997 0.000
Z70.1 Counselling related to patient's sexual behaviour and orientation
0.003 0.997 0.000
Z70.0 Counselling related to sexual attitude
0.003 0.997 0.000
Z74.9 Problem related to care-provider dependency, unspecified
0.003 0.997 0.000
M79.83 Other specified soft tissue disorders (Forearm)
0.003 0.997 0.000
M79.79 Fibromyalgia (Site unspecified)
0.003 0.997 0.000
M79.4 Hypertrophy of (infrapatellar) fat pad
0.003 0.997 0.000
M79.46 Hypertrophy of (infrapatellar) fat pad (Lower leg)
0.003 0.997 0.000
M79.87 Other specified soft tissue disorders (Ankle and foot)
0.003 0.997 0.000
M79.5 Residual foreign body in soft tissue
0.003 0.997 0.000
O36.5 Maternal care for poor foetal growth
0.003 0.997 0.000
Y84.9 Medical procedure, unspecified
0.003 0.997 0.000
M79.98 Soft tissue disorder, unspecified (Other)
0.003 0.997 0.000
T85.5 Mechanical complication of gastro-intestinal prosthetic devices, implants and grafts
0.003 0.997 0.000
Y84.7 Blood-sampling
0.003 0.997 0.000
Y84.5 Insertion of gastric or duodenal sound
0.003 0.997 0.000
Y84.3 Shock therapy
0.003 0.997 0.000
M77.91 Enthesopathy, unspecified (Shoulder region)
0.003 0.997 0.000
M79.70 Fibromyalgia (Multiple sites)
0.003 0.997 0.000
Z74.0 Reduced mobility
0.003 0.997 0.000
M79.3 Panniculitis, unspecified
0.002 0.997 0.000
M79.54 Residual foreign body in soft tissue (Hand)
0.003 0.997 0.000
Z74.8 Other problems related to care-provider dependency
0.002 0.997 0.000
M79.97 Soft tissue disorder, unspecified (Ankle and foot)
0.002 0.997 0.000
M79.95 Soft tissue disorder, unspecified (Pelvic region and thigh)
0.002 0.997 0.000
M79.94 Soft tissue disorder, unspecified (Hand)
0.002 0.997 0.000
M79.93 Soft tissue disorder, unspecified (Forearm)
0.002 0.997 0.000
M79.92 Soft tissue disorder, unspecified (Upper arm)
0.002 0.997 0.000
M79.91 Soft tissue disorder, unspecified (Shoulder region)
0.002 0.997 0.000
M79.90 Soft tissue disorder, unspecified (Multiple sites)
0.002 0.997 0.000
K22.9 Disease of oesophagus, unspecified
0.003 0.997 0.000
M79.78 Fibromyalgia (Other)
0.002 0.997 0.000
M79.77 Fibromyalgia (Ankle and foot)
0.002 0.997 0.000
M79.76 Fibromyalgia (Lower leg)
0.002 0.997 0.000
M79.75 Fibromyalgia (Pelvic region and thigh)
0.002 0.997 0.000
M79.74 Fibromyalgia (Hand)
0.002 0.997 0.000
M79.73 Fibromyalgia (Forearm)
0.002 0.997 0.000
M79.72 Fibromyalgia (Upper arm)
0.002 0.997 0.000
M79.71 Fibromyalgia (Shoulder region)
0.002 0.997 0.000
H40 Glaucoma
0.003 0.997 0.000
M79.2 Neuralgia and neuritis, unspecified
0.002 0.997 0.000
R01.1 Cardiac murmur, unspecified
0.003 0.997 0.000
Z76.5 Malingerer [conscious situation]
0.002 0.997 0.000
Z76.4 Other boarder in health-care facility
0.002 0.997 0.000
Z76.3 Healthy person accompanying sick person
0.002 0.997 0.000
Z76.2 Health supervision and care of other healthy infant and child
0.002 0.997 0.000
Z76.1 Health supervision and care of foundling
0.002 0.997 0.000
Z76.0 Issue of repeat prescription
0.002 0.997 0.000
M79.53 Residual foreign body in soft tissue (Forearm)
0.002 0.997 0.000
M79.88 Other specified soft tissue disorders (Other)
0.002 0.997 0.000
Y84.4 Aspiration of fluid
0.002 0.997 0.000
M79.49 Hypertrophy of (infrapatellar) fat pad-Site unspec
0.002 0.998 0.000
M79.48 Hypertrophy of (infrapatellar) fat pad (Other)
0.002 0.998 0.000
M79.47 Hypertrophy of (infrapatellar) fat pad (Ankle and foot)
0.002 0.998 0.000
M79.45 Hypertrophy of (infrapatellar) fat pad (Pelvic region and thigh)
0.002 0.998 0.000
M79.44 Hypertrophy of (infrapatellar) fat pad (Hand)
0.002 0.998 0.000
M79.43 Hypertrophy of (infrapatellar) fat pad (Forearm)
0.002 0.998 0.000
M79.42 Hypertrophy of (infrapatellar) fat pad (Upper arm)
0.002 0.998 0.000
M79.41 Hypertrophy of (infrapatellar) fat pad (Shoulder region)
0.002 0.998 0.000
M79.40 Hypertrophy of (infrapatellar) fat pad (Multiple sites)
0.002 0.998 0.000
M79.82 Other specified soft tissue disorders (Upper arm)
0.002 0.998 0.000
Y49.2 Other and unspecified antidepressants
0.002 0.998 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.002 0.998 0.000
M79.96 Soft tissue disorder, unspecified (Lower leg)
0.002 0.998 0.000
M79.59 Residual foreign body in soft tissue (Site unspecified)
0.002 0.998 0.000
M79.57 Residual foreign body in soft tissue (Ankle and foot)
0.002 0.998 0.000
M79.56 Residual foreign body in soft tissue (Lower leg)
0.002 0.998 0.000
M79.55 Residual foreign body in soft tissue (Pelvic region and thigh)
0.002 0.998 0.000
M79.52 Residual foreign body in soft tissue (Upper arm)
0.002 0.998 0.000
M79.51 Residual foreign body in soft tissue (Shoulder region)
0.002 0.998 0.000
M79.50 Residual foreign body in soft tissue (Multiple sites)
0.002 0.998 0.000
Y49.5 Other antipsychotics and neuroleptics
0.002 0.998 0.000
Y53.4 Other laxatives
0.002 0.998 0.000
M79.1 Myalgia
0.002 0.998 0.000
L71 Rosacea
0.002 0.998 0.000
M79.58 Residual foreign body in soft tissue (Other)
0.002 0.998 0.000
M79.27 Neuralgia and neuritis, unspecified (Ankle and foot)
0.002 0.998 0.000
H40.3 Glaucoma secondary to eye trauma
0.002 0.998 0.000
M79.26 Neuralgia and neuritis, unspecified (Lower leg)
0.002 0.998 0.000
H40.2 Primary angle-closure glaucoma
0.002 0.998 0.000
U82-U85 Resistance to antimicrobial and antineoplastic drugs
0.002 0.998 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.002 0.998 0.000
K12.0 Recurrent oral aphthae
0.002 0.998 0.000
Z76.9 Persons encountering health services in unspecified circumstances
0.002 0.998 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.002 0.998 0.000
Y57.5 X-ray contrast media
0.002 0.998 0.000
M79.11 Myalgia (Shoulder region)
0.002 0.998 0.000
M79.39 Panniculitis, unspecified (Site unspecified)
0.002 0.998 0.000
M79.38 Panniculitis, unspecified (Other)
0.002 0.998 0.000
M79.37 Panniculitis, unspecified (Ankle and foot)
0.002 0.998 0.000
M79.36 Panniculitis, unspecified (Lower leg)
0.002 0.998 0.000
M79.35 Panniculitis, unspecified (Pelvic region and thigh)
0.002 0.998 0.000
M79.34 Panniculitis, unspecified (Hand)
0.002 0.998 0.000
M79.33 Panniculitis, unspecified (Forearm)
0.002 0.998 0.000
M79.32 Panniculitis, unspecified (Upper arm)
0.002 0.998 0.000
M79.31 Panniculitis, unspecified (Shoulder region)
0.002 0.998 0.000
M79.30 Panniculitis, unspecified (Multiple sites)
0.002 0.998 0.000
Z00.0 General medical examination
0.002 0.998 0.000
L43 Lichen planus
0.000 0.998 0.002
H40.6 Glaucoma secondary to drugs
0.002 0.998 0.000
M79.10 Myalgia (Multiple sites)
0.002 0.998 0.000
M79.25 Neuralgia and neuritis, unspecified (Pelvic region and thigh)
0.002 0.998 0.000
M79.24 Neuralgia and neuritis, unspecified (Hand)
0.002 0.998 0.000
M79.23 Neuralgia and neuritis, unspecified (Forearm)
0.002 0.998 0.000
M79.22 Neuralgia and neuritis, unspecified (Upper arm)
0.002 0.998 0.000
M79.21 Neuralgia and neuritis, unspecified (Shoulder region)
0.002 0.998 0.000
N39.9 Disorder of urinary system, unspecified
0.002 0.998 0.000
Y46.4 Iminostilbenes
0.002 0.998 0.000
Z41.1 Other plastic surgery for unacceptable cosmetic appearance
0.000 0.998 0.002
H40.5 Glaucoma secondary to other eye disorders
0.002 0.998 0.000
K12 Stomatitis and related lesions
0.002 0.998 0.000
Y57 Other and unspecified drugs and medicaments
0.002 0.998 0.000
H40.4 Glaucoma secondary to eye inflammation
0.002 0.998 0.000
X23.9 Unspecified place
0.002 0.998 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.002 0.998 0.000
M79.20 Neuralgia and neuritis, unspecified (Multiple sites)
0.002 0.998 0.000
S42.30 Fracture of shaft of humerus (closed)
0.002 0.998 0.000
L43.8 Other lichen planus
0.000 0.998 0.002
M79.0 Rheumatism, unspecified
0.002 0.998 0.000
R94.5 Abnormal results of liver function studies
0.002 0.998 0.000
Y49.9 Psychotropic drug, unspecified
0.002 0.998 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.002 0.998 0.000
Y49.7 Psychostimulants with abuse potential
0.002 0.998 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.002 0.998 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.002 0.998 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.002 0.998 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.002 0.998 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.002 0.998 0.000
Y57.6 Other diagnostic agents
0.002 0.998 0.000
Z76.8 Persons encountering health services in other specified circumstances
0.002 0.998 0.000
G70.0 Myasthenia gravis
0.000 0.998 0.002
Y48 Anaesthetics and therapeutic gases
0.002 0.998 0.000
M71.38 Other bursal cyst (Other)
0.002 0.998 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.002 0.998 0.000
Y48.4 Anaesthetic, unspecified
0.002 0.998 0.000
Y54.4 Loop [high-ceiling] diuretics
0.002 0.998 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.002 0.998 0.000
M77.9 Enthesopathy, unspecified
0.002 0.998 0.000
M79.28 Neuralgia and neuritis, unspecified (Other)
0.002 0.998 0.000
K82.9 Disease of gallbladder, unspecified
0.000 0.998 0.002
M79.17 Myalgia (Ankle and foot)
0.002 0.998 0.000
M79.14 Myalgia (Hand)
0.002 0.998 0.000
M79.13 Myalgia (Forearm)
0.002 0.998 0.000
M79.12 Myalgia (Upper arm)
0.002 0.998 0.000
L71.8 Other rosacea
0.002 0.998 0.000
L71.0 Perioral dermatitis
0.002 0.998 0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.002 0.998 0.000
J00 Acute nasopharyngitis [common cold]
0.000 0.998 0.002
M79.15 Myalgia (Pelvic region and thigh)
0.002 0.998 0.000
L71.1 Rhinophyma
0.002 0.998 0.000
M79.01 Rheumatism, unspecified (Shoulder region)
0.002 0.998 0.000
W21.9 Unspecified place
0.002 0.998 0.000
Y41.0 Sulphonamides
0.002 0.998 0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.002 0.998 0.000
U84 Resistance to other antimicrobial drugs
0.002 0.998 0.000
U83 Resistance to other antibiotics
0.002 0.998 0.000
U82 Resistance to betalactam antibiotics
0.002 0.998 0.000
U85 Resistance to antineoplastic drugs
0.002 0.998 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.002 0.998 0.000
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.998 0.002
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.002 0.998 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.002 0.998 0.000
Y53.7 Emetics
0.002 0.998 0.000
Y53.6 Antidiarrhoeal drugs
0.002 0.998 0.000
Y53.5 Digestants
0.002 0.998 0.000
Y53.3 Saline and osmotic laxatives
0.002 0.998 0.000
Y53.2 Stimulant laxatives
0.002 0.998 0.000
Y53.0 Histamine H2-receptor antagonists
0.002 0.998 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.002 0.998 0.000
Y45.8 Other analgesics and antipyretics
0.002 0.998 0.000
Y45.5 4-Aminophenol derivatives
0.002 0.998 0.000
Y59 Other and unspecified vaccines and biological substances
0.002 0.998 0.000
Y58 Bacterial vaccines
0.002 0.998 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.002 0.998 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.002 0.998 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.002 0.998 0.000
M23.51 Chronic instability of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)
0.000 0.998 0.002
Y53.1 Other antacids and anti-gastric-secretion drugs
0.002 0.998 0.000
M77.94 Enthesopathy, unspecified (Hand)
0.002 0.998 0.000
L43.3 Subacute (active) lichen planus
0.000 0.998 0.002
L43.2 Lichenoid drug reaction
0.000 0.998 0.002
L43.1 Bullous lichen planus
0.000 0.998 0.002
L43.0 Hypertrophic lichen planus
0.000 0.998 0.002
W57.8 Other specified place
0.002 0.998 0.000
Y45.1 Salicylates
0.002 0.998 0.000
Y42.7 Androgens and anabolic congeners
0.002 0.998 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.002 0.998 0.000
M79.19 Myalgia (Site unspecified)
0.002 0.998 0.000
M79.67 Pain in limb (Ankle and foot)
0.002 0.998 0.000
Y42.5 Other oestrogens and progestogens
0.002 0.998 0.000
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)
0.000 0.998 0.002
S82.8 Fractures of other parts of lower leg
0.000 0.998 0.002
Y40.6 Rifamycins
0.002 0.998 0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.002 0.998 0.000
Y41.4 Anthelminthics
0.002 0.998 0.000
Y41.3 Other antiprotozoal drugs
0.002 0.998 0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.002 0.998 0.000
Y41.1 Antimycobacterial drugs
0.002 0.998 0.000
Y48.2 Other and unspecified general anaesthetics
0.002 0.998 0.000
Y57.7 Vitamins, not elsewhere classified
0.002 0.998 0.000
Y57.4 Pharmaceutical excipients
0.002 0.998 0.000
Y57.3 Alcohol deterrents
0.002 0.998 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.002 0.998 0.000
Y57.1 Lipotropic drugs
0.002 0.998 0.000
Y57.0 Appetite depressants [anorectics]
0.002 0.998 0.000
Z04.3 Examination and observation following other accident
0.002 0.998 0.000
M62.59 Muscle wasting and atrophy, not elsewhere classified (Site unspecified)
0.002 0.998 0.000
M79.07 Rheumatism, unspecified (Ankle and foot)
0.002 0.998 0.000
M79.06 Rheumatism, unspecified (Lower leg)
0.002 0.998 0.000
M79.05 Rheumatism, unspecified (Pelvic region and thigh)
0.002 0.998 0.000
M79.04 Rheumatism, unspecified (Hand)
0.002 0.998 0.000
M79.03 Rheumatism, unspecified (Forearm)
0.002 0.998 0.000
M79.02 Rheumatism, unspecified (Upper arm)
0.002 0.998 0.000
M84.17 Nonunion of fracture [pseudarthrosis] (Ankle and foot)
0.002 0.998 0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.